HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adjuvant chemotherapy in a pregnant woman with endodermal sinus tumor of the ovary.

AbstractBACKGROUND:
The administration of chemotherapeutic drugs during pregnancy is rare. We describe a case of malignant ovarian tumor complicating pregnancy.
CASE:
After laparotomy at 18 weeks of gestation, the patient received three courses of cisplatin, vinblastine, and bleomycin. Elective cesarean delivery was performed at 31 weeks of gestation. A normal infant was delivered, and no evidence of tumor recurrence was observed. Metastasis to the liver was detected in the fifth month after delivery. However, this was treated successfully with three courses of cisplatin, etoposide, and bleomycin. There was no evidence of recurrence observed at 65 months after the initial treatment.
CONCLUSION:
Although the risk of chemotherapy to the fetus cannot be assessed based on a single case, this experience is encouraging.
AuthorsMakoto Motegi, Satoshi Takakura, Hirokuni Takano, Tadao Tanaka, Kazunori Ochiai
JournalObstetrics and gynecology (Obstet Gynecol) Vol. 109 Issue 2 Pt2 Pg. 537-40 (Feb 2007) ISSN: 0029-7844 [Print] United States
PMID17267887 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Bleomycin
  • Vinblastine
  • Cisplatin
Topics
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Bleomycin (administration & dosage)
  • Cesarean Section
  • Chemotherapy, Adjuvant
  • Cisplatin (administration & dosage)
  • Combined Modality Therapy
  • Diagnosis, Differential
  • Endodermal Sinus Tumor (diagnosis, drug therapy, pathology, surgery)
  • Female
  • Humans
  • Infant, Newborn
  • Ovarian Neoplasms (diagnosis, drug therapy, pathology, surgery)
  • Pregnancy
  • Pregnancy Complications, Neoplastic (diagnosis, drug therapy, pathology, surgery)
  • Pregnancy Trimester, Third
  • Prenatal Care
  • Prenatal Diagnosis
  • Vinblastine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: